Clinical Trial Update: Evaluation of Efficacy and Safety of Neoadjuvant Treatment With Pamrevlumab in Combination With Chemotherapy (Either Gemcitabine Plus Nab-paclitaxel or FOLFIRINOX) in Participants With Locally Advanced, Unresectable Pancreatic Cancer [Phase 3]

View source ↗

Summary

A Phase 3 neoadjuvant trial evaluating pamrevlumab in combination with chemotherapy (gemcitabine plus nab-paclitaxel or FOLFIRINOX) for locally advanced, unrese…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Gemcitabine (Gemcitabine)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Nab-paclitaxel (paclitaxel protein-bound)
• OXALIPLATIN (Oxaliplatin)
• Pamrevlumab (pamrevlumab)

Snippet

Sponsor: Kyntra Bio | Conditions: Pancreatic Cancer Non-resectable | Phase 3 | Status: COMPLETED | Results posted: 2024-11-05